Staphylococcus aureus is a versatile Gram-positive bacterium capable of causing a spectrum of illnesses ranging from superficial skin infections to life-threatening endocarditis and sepsis. Central to ...

Staphylococcus aureus remains a leading cause of hospital- and community-acquired infections worldwide, ranging from superficial skin lesions to life-threatening pneumonia and sepsis. Proteomic ...

Antibiotics are the old medicine cabinet standby for treating infections caused by multidrug-resistant Staphylococcus aureus, but as antimicrobial resistance continues to mount globally, scientists ...

Recently, a research team led by Prof. Sun Baolin from the University of Science and Technology of China (USTC) revealed the mechanism of transcriptional regulation via S-nitrosylation for vancomycin ...

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, ...

Staphylococcus aureus (S. aureus) has a complicated relationship with humans. While this commensal bacterium colonizes approximately 20-30 percent of human nasal cavities and is a member of the human ...

A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants of the dangerous pathogenic bacteria Staphylococcus aureus. Viruses of ...

A promising approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was safe and highly effective in a Phase 2 clinical trial. The new study ...

SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S.

The rapid identification and genomic analysis of zoonotic pathogens are critical for safeguarding public health and controlling outbreaks. PathoBase, an advanced computational platform, provides a ...